Doxorubicin and Weight Gain: An Overview
Weight gain is a common complaint in people taking
doxorubicin hydrochloride (
Adriamycin®, Doxil
®). Weight gain with doxorubicin occurs in up to 14.4 percent of people taking the drug. However, it is difficult to tell if this weight gain is caused by doxorubicin or by other factors, due to the way clinical studies of doxorubicin were designed.
Doxorubicin and Weight Gain: Understanding Clinical Trials
Before most medicines are approved, they must go through several clinical studies where thousands of people are given a particular medicine and are then compared to a group of people not given the medicine. In these studies, the side effects are always carefully documented. As a result, it is possible to see what side effects occur, how often they appear, and how they compare to the group not taking the medicine.
However, sometimes, it is unethical to not treat a condition. This is the case in cancer studies. Because it would be unethical to not treat cancer, doxorubicin cannot be compared to a placebo ("sugar pill"). Therefore, it is difficult to tell if a side effect is due to doxorubicin, other factors, or a combination of both. Additionally, doxorubicin was used in combination with another chemotherapy medication,
cyclophosphamide (
Cytoxan®, Neosar
®), so it is difficult to know how much of the weight gain was due to doxorubicin and how much was due to cyclophosphamide.